Latest Decipher Stories
Data from Multiple Studies Include Potential Ability for Technology to Further Subtype Patients, Guide Treatment Decisions SAN DIEGO, Feb.
Multiple Studies of Decipher Prostate Cancer Classifier Presented at 2015 ASCO Genitourinary Symposium SAN DIEGO, Feb.
Decipher is the first genomic test for postoperative prostate cancer to gain Medicare coverage SAN DIEGO, Jan.
For the first time, a nationwide project designed to use genetics to diagnose rare diseases will allow recent massive advances in genomics to translate into patient care in the UK’s National Health Service (NHS).
CAMBRIDGE, Massachusetts, November 17, 2014 /PRNewswire/ -- Direct linking between exome data in DECIPHER and European Journal of
Builds on initial collaboration with Mayo Clinic that led to the development and commercialization of Decipher in patients following prostate surgery SAN DIEGO, Nov.
SAN DIEGO, Oct.
SAN DIEGO, Sept. 25, 2014 /PRNewswire/ -- GenomeDx Biosciences today announced that it has entered into a contractual agreement with MultiPlan, Inc. for diagnostic laboratory testing.
Oral presentation at American Society for Radiation Oncology Annual Meeting describes Decipher's ability to identify high-risk prostate cancer patients that may benefit from radiation therapy after
Data presented at American Society for Radiology (ASTRO) Annual Meeting in San Francisco SAN FRANCISCO, Sept.
- Emitting flashes of light; glittering.